Baby Formula Recalls Hit Iowa Manufacturing Amid FDA Overhaul

Recent baby formula recalls tied to bacterial contamination are raising serious questions about the Food and Drug Administration's ability to protect American families. With an Iowa manufacturing facility directly involved in the fallout, the debate over federal oversight and government efficiency hits close to home. Following Trump administration efforts to streamline a bloated federal bureaucracy, the FDA lost around 3,100 employees. Now, critics and industry watchers are asking if the agency is focusing its remaining resources on the right priorities.

How are Iowa manufacturers involved in the formula recalls?

ByHeart, which manufactures its infant formula in Iowa, initiated a voluntary recall last November after an infant botulism outbreak linked to 48 hospitalizations across 17 states. Investigative reporting by Food Safety Magazine later revealed that ByHeart used whole milk powder from Organic West. That same supplier also provided ingredients to Nara Organics, which recalled its own formula earlier this month following a lawsuit from a baby who allegedly contracted botulism.

A ByHeart spokesperson stated the company only learned of the shared milk powder supplier when the FDA posted an update on June 26, adding that the FDA's root cause investigation is now focusing on third-party ingredients. The company is rolling out new safety measures as the investigation continues.

Did Trump's FDA cuts compromise food safety?

In March, the FDA launched Operation Stork Speed to expand safe and reliable formula options for American families. However, in May, then-commissioner Martin Makary told Congress the FDA had lost around 3,100 employees due to the Trump administration's reorganization. Makary departed the agency that same month.

Tom Brenna, a medical and food science expert who helped design regulations for Operation Stork Speed, said there has been no movement on the initiative since summer 2025. An FDA spokesperson maintains the operation is continuing as planned and claims the administration more than doubled its infant formula staffing. The agency also requested Congress mandate more accountability from the industry, including requiring companies to report positive pathogen tests.

Sarah Mayne, former director of the FDA's center for food safety and applied nutrition, argued the agency is doing